Immunefi vs Morpho — how do they compare? Immunefi trades at Rp24.67 (market cap Rp27,03M, Rp39,91M 24h volume), while Morpho trades at Rp34,915 (market cap Rp17,97T, Rp167,02M 24h volume). The key difference: Morpho is far larger — about 664816.9× Immunefi's market cap, and Immunefi's circulating supply is 873,4M / 10B IMU (9%) versus 516,6M / 1B MORPHO (52%) for Morpho. Which is the better fit depends on your goals — on Pluang, investors hold Immunefi for 5 Days and Morpho for 16 Days on average.
| IMU | MORPHO | |
|---|---|---|
Market Cap | Rp27,03M | Rp17,97T |
Volume (24h) | Rp39,91M | Rp167,02M |
Circulating Supply | 873,4M / 10B IMU (9%) | 516,6M / 1B MORPHO (52%) |
Typical Hold Time | 5 Days | 16 Days |
Signals from Pluang's Aura AI — not financial advice
Immunefi (IMU) presents a unique crypto asset with a modest market cap of Rp27.03M and only 9% circulating supply, indicating significant token lockup. The 5-day average hold time suggests short-term trading activity. Current technical analysis is limited due to missing price data, but the low circulation rate and small market cap point to high volatility potential. Recent news coverage appears to focus on corporate equity analysis rather than blockchain fundamentals, creating information asymmetry for crypto investors.
Overall outlook remains speculative with limited fundamental data. Key opportunity lies in potential token unlocks and ecosystem growth, while major risks include extreme volatility from low liquidity, regulatory uncertainty, and lack of clear crypto-specific utility. Investors should approach with caution given the asset's early stage and limited market data availability.
Morpho shows bullish technical momentum with a current price of Rp35,260, trading near resistance levels. The asset maintains strong moving average signals while oscillators remain neutral. With 52% of the max supply in circulation and an average hold time of 16 days, the token demonstrates moderate distribution and holding patterns. No major protocol updates or ecosystem developments were reported recently.
Overall outlook is cautiously optimistic with technical strength but limited fundamental catalysts. Key opportunities include potential breakout above resistance levels, while risks involve low liquidity and the absence of recent ecosystem developments. Investors should monitor for protocol updates and increased trading volume.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Immunefi is a security-focused ecosystem token designed to reward contributions to blockchain safety. It aligns protocols, researchers, and communities through bug bounties, staking, and governance incentives. The ecosystem also integrates AI to enhance threat detection and scale protection as the on-chain economy grows.
Read more on IMU →Morpho is an open, efficient, and trustless platform designed for earning yield and borrowing assets. Lenders utilize Morpho Vaults to maximize their returns, while borrowers gain access to assets through Morpho Markets. Its permissionless infrastructure empowers developers and businesses to create markets, curate vaults, and build applications. With immutable contracts, isolated lending markets, improved interest rates, and low gas fees, Morpho offers efficiency, flexibility, and a developer-friendly environment.
Read more on MORPHO →